A Survey of Hospital and Community Pharmacists’ Knowledge and Awareness Regarding Clinical Trials

• Published in: Iyakuhin Johogaku Vol. 15; no. 2; pp. 83 - 89
• Main Authors: Okazawa, Katsuko, Sasaki, Shinichi, Mizukoshi, Hiroki, Takehara, Emiko, Wakabayashi, Masato, Matsuoka, Yoshiki
• Format: Journal Article
• Language: English
• Published: Japanese Society of Drug Informatics 2013; 一般社団法人 日本医薬品情報学会
• Subjects: awareness; clinical trials; knowledge; pharmacists; questionnaire survey
• ISSN: 1345-1464; 1883-423X
• DOI: 10.11256/jjdi.15.83

Objective: The present study investigated awareness and knowledge about clinical trials among pharmacists working in the Nagano Hokushin area as well as their contribution to the enlightenment of clinical trial. Methods: A questionnaire survey of clinical trials was conducted to evaluate levels of interest, impressions, sources of information, and knowledge among hospital and community pharmacists. Results: We received responses from 77 hospital and 67 community pharmacists. The levels of interest in clinical trials were not significantly different between hospital and community pharmacists. About impressions, hospital pharmacists thought that clinical trials were “a new development.” Contrarily, community pharmacists thought that clinical trials were “a field that they were seldom concerned with.” About sources of information, hospital pharmacists found that “study meetings” were the most informative. More community pharmacists than hospital pharmacists chose “general reports, for example, newspapers and televisions” as a source of information, and similarly more community pharmacists indicated that they had “few opportunities for obtaining information about clinical trials.” About knowledge, the percentage of correct answers about clinical trials between hospital and community pharmacists was not significantly different. A higher percentage of community pharmacists than hospital pharmacists answered unknown. Conclusion: Hospital and community pharmacists had different impressions and knowledge about clinical trials probably because of differences in sources of information and its access. Henceforth, study meetings involving educational material about clinical trials should be held for discussing fundamental knowledge about the methods and structure of clinical trials and for discussing case studies wherein patients consult pharmacists about clinical trials.